DGAT2 (diacylglycerol O-acyltransferase 2)

2017-08-01  

Identity

HGNC
LOCATION
11q13.5
LOCUSID
ALIAS
ARAT,GS1999FULL,HMFN1045
FUSION GENES

Other Information

Locus ID:

NCBI: 84649
MIM: 606983
HGNC: 16940
Ensembl: ENSG00000062282

Variants:

dbSNP: 84649
ClinVar: 84649
TCGA: ENSG00000062282
COSMIC: DGAT2

RNA/Proteins

Gene IDTranscript IDUniprot
ENSG00000062282ENST00000228027Q96PD7
ENSG00000062282ENST00000376262Q96PD7
ENSG00000062282ENST00000603276S4R383
ENSG00000062282ENST00000604733S4R3S3
ENSG00000062282ENST00000604935S4R3Z3
ENSG00000062282ENST00000605099S4R449

Expression (GTEx)

0
50
100
150
200

Pathways

PathwaySourceExternal ID
Glycerolipid metabolismKEGGko00561
Glycerolipid metabolismKEGGhsa00561
Metabolic pathwaysKEGGhsa01100
Fat digestion and absorptionKEGGko04975
Fat digestion and absorptionKEGGhsa04975
Triacylglycerol biosynthesisKEGGhsa_M00089
Triacylglycerol biosynthesisKEGGM00089
MetabolismREACTOMER-HSA-1430728
Metabolism of lipids and lipoproteinsREACTOMER-HSA-556833
Fatty acid, triacylglycerol, and ketone body metabolismREACTOMER-HSA-535734
Triglyceride BiosynthesisREACTOMER-HSA-75109
Phospholipid metabolismREACTOMER-HSA-1483257
Glycerophospholipid biosynthesisREACTOMER-HSA-1483206
Acyl chain remodeling of DAG and TAGREACTOMER-HSA-1482883

References

Pubmed IDYearTitleCitations
385001572024The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications.2
385001572024The role of DGAT1 and DGAT2 in regulating tumor cell growth and their potential clinical implications.2
375163082023Preferential lipolysis of DGAT1 over DGAT2 generated triacylglycerol in Huh7 hepatocytes.1
377794212023The roles of DGAT1 and DGAT2 in human myotubes are dependent on donor patho-physiological background.1
375163082023Preferential lipolysis of DGAT1 over DGAT2 generated triacylglycerol in Huh7 hepatocytes.1
377794212023The roles of DGAT1 and DGAT2 in human myotubes are dependent on donor patho-physiological background.1
352327752022DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.13
352327752022DGAT2 Inhibition Potentiates Lipid Droplet Formation To Reduce Cytotoxicity in APOL1 Kidney Risk Variants.13
346358552021ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.58
346358552021ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials.58
325060382020Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis.25
325060382020Obesity promotes gastric cancer metastasis via diacylglycerol acyltransferase 2-dependent lipid droplets accumulation and redox homeostasis.25
310780412019Dgat2 reduces hepatocellular carcinoma malignancy via downregulation of cell cycle-related gene expression.11
310780412019Dgat2 reduces hepatocellular carcinoma malignancy via downregulation of cell cycle-related gene expression.11
296042902018Intestinal Failure and Aberrant Lipid Metabolism in Patients With DGAT1 Deficiency.46

Citation

Dessen P

DGAT2 (diacylglycerol O-acyltransferase 2)

Atlas Genet Cytogenet Oncol Haematol. 2017-08-01

Online version: http://atlasgeneticsoncology.org/gene/57006/dgat2-(diacylglycerol-o-acyltransferase-2)